55 /100
HIGH RISK
Score updated Jul 14, 2026

NVNO — enVVeno Medical Corporation Dilution Risk Tracker

Track NVNO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NVNO — Get alerts when the score changes →

As of July 14, 2026, enVVeno Medical Corporation (NVNO) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. enVVeno Medical Corporation has a market capitalization of $7.56M, 667.7K shares outstanding, 1 institutional holders tracked. Key dilution vectors include 861.00M outstanding warrants, approximately 19 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
25
📊 Float Risk
45
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
📜 Warrant Exercise 60%
• Massive warrant overhang: 128956% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion 60%
• Major convertible overhang: 34% potential dilution
• Convertible risk score very high (85/100)
🔔 Track NVNO — Get forecast alerts →

💹 Market Data

Market Cap$7.56M
Shares Outstanding667.7K
Float486.1K
Cash$24.93M
Debt$603.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 99.9% shares (2026Q1 vs prior)
1 institutional holders · 6.6K shares
#1 MORGAN STANLEY 6.6K shares

📉 Short Interest

Short Interest10.8K
Days to Cover1.4
% of Float2.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2018
4 INSIDER TRANSACTION Mar 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NVNO Shareholders

enVVeno Medical Corporation (NVNO) has a DilutionScore of 55/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 861.0M outstanding warrants for NVNO. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for NVNO in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NVNO alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track NVNO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NVNO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NVNO
📊 NVNO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NVNO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.